Delivery Order SPE2DB20D3103-SPE2DB24FP9U5
Award Date
8/21/24
Potential Completion Date
9/12/24
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $82,935.48 firm-fixed-price contract is for the supply of NovoSeven RT 5 mg vials, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $50,818.95, is for the supply of NovoSeven RT 5 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of NovoSeven RT 5 mg vials to the Defense Logistics Agency (DLA). The $80,051.84 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 14, 2025, with a completion date of April 4, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,760.43, is for the delivery of NovoSeven RT 2 mg vials, a specialty medication used in the treatment of hemophilia. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of March 5, 2024. The award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,750.80 firm fixed-price delivery order is for the supply of 4,566,658,071 units of the medication NovoSeven RT 5 mg vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,760.43, is for the delivery of 4563398480 NOVOSeven RT 2 MG vials and has a completion date of February 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 2 mg vials of the medication NovoSeven RT, with a ceiling value of $2,760.43 and an ultimate completion date of December 2, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a large...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the supply of 2 mg vials of the medication NOVOSEVEN RT, with a potential value of $13,802.15 and a performance period through February 22, 2024. This contract does not have a set-aside designation. Amerisourcebergen...
The Defense Logistics Agency awarded a $20,007 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562280380 NOVOSEVEN RT 5 MG VIALS. As the prime contractor, Amerisourcebergen will supply the blood coagulation factor VIIa recombinant therapeutic product to the Defense Logistics Agency in support of the agency's medical logistics programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from September 22, 2023 through...